drugset / Trial / NCT02453750

Airway Inflammation in Congenital Diaphragmatic Hernia Patients

NCT02453750

Completed 21 enrolled The Hospital for Sick Children
NaSingle-groupOpen-labelDiagnostic

Summary

We propose to examine Congenital Diaphragmatic Hernia (CDH) patients for evidence of airway inflammation as a first step to characterize the reported bronchodilator responsiveness. Airway biopsy studies are invasive and thus we propose to perform induced sputum studies to document the amount and type of inflammation present. Another ancillary non-invasive measure of airway inflammation that we will use is exhaled nitric oxide (NO). The primary objective of this study is to determine if CDH patients have any evidence of airway inflammation. The hypothesis of this study is that children with CDH do not have evidence of airway inflammation associated with bronchodilator responsiveness. Based on this information, treatment for CDH patients will hopefully be more accurate and appropriate for their specific needs.

Timeline

Start
2012-02
Primary completion
2013-10
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Background Hypersaline Unknown 3 % Inhaled
Background Salbutamol Unknown 200 ug Inhaled